GravaStar Unveils Mercury K98 Pro: A Cyberpunk-Engineered 98% Mechanical Keyboard with 8000Hz Polling, an 8000mAh Battery, and a Built-In Smart Display
The CNC-machined, skeletonized 98% layout keyboard pairs flagship-level performance with immersive ambient RGB lighting and a 1.65″ smart TFT display LOS ANGELES,... Read more.
NFT Collectors Call Wall Street Bulls’ “Golden Elon” the Mona Lisa of NFTs After 300x Value Surge
LOS ANGELES, June 22, 2026 /PRNewswire/ —Â Have we found NFT’s Mona Lisa? In a digital collectibles market full of fleeting enthusiasm, one NFT is beginning... Read more.
Incisive Launches Portal to End the Administrative Burden of Managing Multiple Dental Relationships
The Incisive portal consolidates case tracking, billing, and lab management across every Incisive partner lab, giving practices the visibility to deliver better... Read more.
Bold Therapeutics to Participate in 2026 Metals in Medicine Gordon Research Conference
VANCOUVER, BC, June 22, 2026 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics... Read more.
Incisive Launches Portal to End the Administrative Burden of Managing Multiple Dental Relationships
The Incisive portal consolidates case tracking, billing, and lab management across every Incisive partner lab, giving practices the visibility to deliver better... Read more.
Bold Therapeutics to Participate in 2026 Metals in Medicine Gordon Research Conference
VANCOUVER, BC, June 22, 2026 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics... Read more.
Panoplai Names Craig Kinnear VP of Insights & Innovation
Seventeen-Year Research Veteran to Strengthen Panoplai’s Intelligence Capabilities NEW YORK, June 22, 2026 /PRNewswire/ — Panoplai, the enterprise platform... Read more.
Bold Therapeutics to Participate in 2026 Metals in Medicine Gordon Research Conference
VANCOUVER, BC, June 22, 2026 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics... Read more.
Panoplai Names Craig Kinnear VP of Insights & Innovation
Seventeen-Year Research Veteran to Strengthen Panoplai’s Intelligence Capabilities NEW YORK, June 22, 2026 /PRNewswire/ — Panoplai, the enterprise platform... Read more.
Panoplai Names Craig Kinnear VP of Insights & Innovation
Seventeen-Year Research Veteran to Strengthen Panoplai’s Intelligence Capabilities NEW YORK, June 22, 2026 /PRNewswire/ — Panoplai, the enterprise platform... Read more.